MARINE EXPLORATION INCORPORATED (OTC: MEXP)
"Up 160.00% on Wednesday"

Detailed Quote: www.otcpicks.com/quotes/MEXP.php

Marine Exploration, Inc., a development stage company, engages in marine treasure hunting expeditions. It involves in the exploration and recovery of deep-ocean shipwrecks, including the marketing, sale, and distribution of recovered artifacts, replicas, merchandise, and books through various retail and wholesale sales channels. The company was incorporated in 1996 as Jenkon International, Inc. and changed its name to Multimedia K.I.D., Inc. in 1999. Later, it changed its name to SYCO, Inc. in 2006; and to Marine Exploration, Inc. in 2007. The company is based in Denver, Colorado.

MEXP News:

August 5 - Marine Exploration Inc. Acquires Ship

Marine Exploration, Inc. (OTC: MEXP) announced that it has executed a bill of sale acquiring the Ocean Lady, a 128 foot, 252 ton research vessel. The Ocean Lady, outfitted to the specifications of Burt Webber of Hispaniola Ventures, Marine's joint venture partner, is docked at Jones Boatyard Miami.

247MGI INCORPORATED (OTC: TOFS)
"Up 116.67% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/TOFS.php

247MGI, Inc. does not have significant operations. It intends to acquire assets or shares of an entity actively engaged in business. Previously, the company, through its subsidiary, Yard Sale Drop Off, Inc., operated as a trading assistant and power seller that assisted others to list and sell items through on-line auctions on the eBay Web site. The company was founded in 1991 and is based in Fort Lauderdale, Florida.

TOFS News:

August 4 - 247MGI to Concentrate on 5 Investment Areas

247MGI, Inc. (OTC: TOFS) (“247MGI”) has singed an agreement with a third party to do Audio and Video presentations worth $120,000. The revenue was generated by 247MGI’s Online Radio show Smallcap Rapp™ which began airing three times a week in the month of June.

247MGI is optimistic revenues will increase as Smallcap Rapp™ continues its new weekly Broadcasts schedule. Revenue for 24MGI will be assisted in the fourth quarter with the release of the Hybrid Player Application and LIVE Video Broadcasts.

247MGI has amended the terms of its funding commitment for $100,000 which can be raised to $200,000 based on performance by the Company to a straight loan versus a Convertible Debenture. The Company had agreed to a 15% discount to market for the entire Debenture on the date of initial funding, but after the recent drop in the price of the Company’s Common stock it would be to costly to continue this type of financing.

VIROGEN INCORPORATED (OTC: VRGI)
"Up 90.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/VRGI.php

Virogen, Inc. is the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide.

VRGI News:

August 6 - Virogen's Distributor Signs Multi-Million Dollar Contracts

Virogen, Inc. (OTC: VRGI) announced that its distributor has signed contracts with the largest poultry producers in Egypt and Saudi Arabia. Vaccine sales of two million in the first year and four to five million thereafter are projected based upon these contracts alone.

While poultry vaccines are now available in the form of a spray or nasal inhalant, the product developed by Virogen is 2000 times more potent than those now on the market. It is injected directly into the chicken embryo and provides immunity up to ten weeks, with the average time to market being six weeks. The trend in protection of livestock is to administer vaccines in-ovo wherever possible, and the Virogen vaccine (inovo-immune) not only fulfills that preference, but is also far cheaper to produce, more effective, and far less expensive to the purchaser than conventional vaccines.

Newcastle is a deadly disease which can decimate entire flocks should an outbreak occur. The most recent outbreak, which occurred in California in the 90s, cost the government over $300 million and the loss of hundreds of thousands of birds. Another outbreak occurred in Texas with similar results. Most outbreaks worldwide go unreported. Fully 85% of the worldwide market resides outside of the United States with Asia, South America, and the Middle East comprising the largest markets. The company has made the strategic decision to concentrate its resources on these world markets in order to maximize revenues and market penetration in the shortest possible time frames. These markets are experiencing rapid growth as protein consumption abroad is rising at a far more rapid rate than in the US domestic market.

To position itself to reach the worldwide market, the company entered into a manufacturing agreement with Romvac, a company headquartered in Bucharest, Romania that has been manufacturing veterinary medicines since 1978. Romvac is an established, well respected manufacturer and meets the highest standards available for a certified distributor. Manufacturing within a European Union member country allows access to the EU market and allows the company to fast track registration of the vaccine in countries worldwide in the shortest possible time. This strategy has not only been cost effective, but has also shortened the commercialization to world markets by several years.

Paul Hogan, CEO of Virogen, Inc., notes that "Every production bird in the world is required to be vaccinated, and since Virogen's vaccine is the only in-ovo patent-protected product on the market, the company anticipates it will capture this exclusive market for several years. With approximately 45 billion birds being produced annually outside of the United States, and consumption growing by close to 30% per annum and expected to increase further, one can anticipate the revenue opportunity for this vaccine is in the tens of millions over the product life cycle."

VERENIUM CORPORATION (NASDAQ: VRNM)
"Up 64.36% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/VRNM.php

Verenium Corporation, together with its subsidiaries, engages in the development and production of specialty enzyme products, and production and commercialization of biofuels. It operates in two segments, Biofuels and Specialty Enzymes. The Biofuels segment focuses on the production and commercialization of biofuels, primarily ethanol from cellulosic biomass. The Specialty Enzymes segment develops customized enzymes for use in alternative fuels, specialty industrial processes, and animal nutrition and health markets. Its products include Fuelzyme-LF, an alpha amylase enzyme, designed to improve the efficiency and economics of ethanol production from corn and other grain, or starch sources; Purifine enzyme for biodiesel applications; Amylase-T Transgenic Corn Amylase; Fuelzyme-CX enzymes for cellulosic ethanol; Purifine for edible oils; Luminase for pulp and paper processing; Phyzyme XP; Quantum phytase; Bayovac SRS that is designed to prevent disease in farmed Atlantic salmon; and Phytase-T, which supplements Quantum phytase. The company has strategic collaborations with Syngenta AG for the discovery and development of a range of novel enzymes; Bunge Oils, Inc. to discover and develop novel enzymes for the production of edible oil products; Cargill Health and Food Technologies to discover and develop novel enzymes for the production of a proprietary Cargill product; BASF AG to develop biocatalytic enzymes; DuPont Bio for the production of ethanol and other chemical products from corn biomass; and Bayer Animal Health to develop and market products to prevent infectious diseases in fish. It operates in North America, South America, Europe, Asia, and the Middle East. The company was founded in 1992 under the name Industrial Genome Sciences, Inc. and changed its name to Diversa Corporation in 1997. Further, it changed its name to Verenium Corporation in 2007. The company is headquartered in Cambridge, Massachusetts.

VRNM News:

August 6 - BP and Verenium Announce Significant Partnership to Accelerate the Commercialization of Cellulosic Ethanol

* Collaboration assembles core capabilities across biofuels value chain to accelerate commercial-scale cellulosic ethanol production using non-food feedstocks
* Initial phase includes $90 million in total funding by BP to Verenium over 18 months

BP and Verenium Corporation (Nasdaq: VRNM) announced the creation of a strategic partnership to accelerate the development and commercialization of cellulosic ethanol. The partnership combines a broad technology platform and operational capabilities in an effort to advance the development of a portfolio of low-cost, environmentally sound cellulosic ethanol production facilities in the United States, and potentially throughout the world. Under the initial phase of the strategic alliance, Verenium is to receive $90 million in total funding from BP over the next 18 months for rights to current and future technology held within the partnership.

"We are very excited and proud to be partnering with BP, a world leader in both the traditional and alternative energy industries that shares our commitment and vision to rapidly evolve next-generation ethanol into a commercial-scale solution for our energy needs," said Carlos A. Riva, President and Chief Executive Officer at Verenium. "In addition to BP's world-class capabilities in traditional energy production, logistics and distribution, their commitment to accelerate the development of the global biofuels market was a significant factor in our decision to partner with BP. In addition, both organizations are aligned on the significant market opportunity and operational imperatives for achieving rapid, commercial-scale success."

"BP is very pleased to be entering this important relationship with Verenium. We believe energy crops like sugar cane, miscanthus and energy cane are the best feedstocks to deliver economic, sustainable and scaleable biofuels to the world. This deal puts us at the front of the cellulosic biofuels game," said Sue Ellerbusch, president of BP Biofuels North America. "In partnering with Verenium, we now have the most advanced technology for transforming these energy grasses to biofuels, increasing our ability to invest earlier in the US to meet the requirements for cellulosic ethanol laid out in the recent energy bill. We also have the possibility of enhancing the productivity of our Brazilian assets. Verenium has already demonstrated the technology, making this real and an appropriate fit with our commitment to bring more sustainable biofuels to the market more quickly."

The initial phase of the strategic alliance utilizes Verenium's advanced technology for cellulosic ethanol production as the platform for a joint development effort between BP and Verenium. The companies have formed a Special Purpose Entity (SPE) that is equally owned by BP and Verenium, will license existing intellectual property from each company and own jointly-developed intellectual property in the field of cellulosic ethanol production. All intellectual property owned prior to the formation of the SPE will be retained by each respective company. Further, the SPE will serve as the licensing entity to enable all cellulosic ethanol production projects.

The financial terms of this initial phase of the strategic alliance include:

A) $45 million, payable in three installments over the next twelve months, for broad access to Verenium's cellulosic ethanol technology platform, production facilities, and employee scientific knowledge and expertise. At closing, Verenium will receive the first $24.5M of this amount.

B) $2.5 million per month to co-fund Verenium's various scientific and technical initiatives within the cellulosic ethanol field. The Companies' joint efforts in the field will be directed by a Joint Development Agreement, the initial term of which is 18 months.

Beyond the initial phase of this alliance, the companies expect to negotiate a second phase of the relationship focused on the development of a Joint Venture (JV) to accelerate the commercial deployment of the technologies from the SPE into commercial-scale cellulosic ethanol production facilities. While the primary and initial focus of the JV will be on facilities jointly owned by BP and Verenium in the United States, the SPE technologies may also be licensable to third-party commercial projects. It is the Companies' intention to negotiate and finalize this second phase of the strategic alliance, including incremental financial terms for co-funding the JV.

Lazard acted as financial advisor to Verenium in connection with the transaction.

ABOUT CELLULOSIC ETHANOL

Cellulosic ethanol is a renewable fuel source produced from biomass-derived products such as sugarcane waste (bagasse), switchgrass, rice straw and wood chips. Cellulose, a long-chain polysaccharide found in nearly all plant life, is the most abundant molecule on earth.

Cellulosic ethanol uses advanced biological science to reduce the cost of ethanol production and enable access to a wide variety of biomass. Unlike traditional ethanol manufactured from corn, cellulosic ethanol production utilizes non-food, plant biomass as its feedstock source. The biomass is first broken down into fermentable sugars using acid or enzymatic hydrolysis and industrial enzymes, after which the sugars are fermented into ethanol using various fermentation organisms. Ethanol produced from cellulosic biomass is believed to have many benefits over first-generation ethanol including, the use of non-food feedstock, substantially greater yield than grain ethanol per acre of feedstock, minimal exposure to volatile commodity price risks across the production process and a more favorable environmental impact. It also offers the potential to deliver significant greenhouse gas emission reductions of 80-90% compared to grain ethanol at GHG emission reductions of 0-70%.(1)

The Energy Bill

The production of cellulosic ethanol in the United States is supported by the Energy Independence and Security Act of 2007, which mandates 21 billion gallons of advanced biofuel production by 2022, of which 16 billion gallons must come from cellulosic ethanol.

ABOUT BP

BP is of one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items. It is the largest oil and gas producer in the U.S. and one of the largest refiners. BP also has a global network of around 25,000 service stations.

BP is a leading player in the global biofuels market. In the US, BP blended and distributed 763 million US gallons of ethanol and about 1 million US gallons of biodiesel during 2007. In Europe, BP sold 344 million liters of ethanol and 847 million liters of biodiesel during 2007. BP's sales of biofuels in 2007 accounted for about 10% of the global biofuels market.

(1) GHG emissions reductions taken from Concawe Well-to-Wheels Report March 2007.

CRUISECAM INTERNATIONAL INCORPORATED (OTC: CCMJ)
"Up 62.50% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/CCMJ.php

CruiseCam International, through its two operating subsidiaries, develops and markets integrated, "in-car" camera mount and recording systems for law enforcement, consumer, commercial and transportation applications, as well as for competition racing cars. The Company's patented technology and industry-first "Cruisecam" offering have been developed since 1996, and are distributed nationwide. For more information, visit www.cruisecam.com.

CCMJ News:

August 4 - CruiseCam Sells Camera Mounts to Las Vegas Metro Police Department

CruiseCam International, Inc. (OTC: CCMJ) has sold camera mounts to the Las Vegas Metro Police Department for officer training purposes.

CruiseCam camera mounts provide versatility that is greatly needed when using multiple vehicles throughout the officer training process. These InCar(TM) mounts are rapidly installed on the seat headrests of each vehicle and can be interchanged with different cameras in different vehicles easily. Additionally, it is the only mount that is behind the shoulder of the police officer which has the further benefit of documenting the officer's actions inside the vehicle as well as outside the vehicle.

This CruiseCam camera mount product is the only one of its kind on the market and the company anticipates broader use of its products in the scope of training different types of drivers, i.e. student drivers who would benefit from being able to visibly see their driving mistakes as opposed to attempting to mentally recall the driving details.

A further application of this product would also extend to commercial vehicle driver training. Also, the product would greatly enhance citizen patrols and neighborhood crime watch programs because it provides a safe, low-cost and covert solution for documenting unwanted criminal activities in urban areas that are often out of the view of many police patrol units.

Additionally, CruiseCam has received its first production supply of CruiseCam long bars and ProStabilizers from the production facilities in China. These products were presented recently to Cinequipwhite; a division of William F. White Intl. Inc. based in Toronto which is the largest company of its kind in Canada, supplying equipment to the motion picture, television and theatre industry. Based on that presentation there will be modifications made which will facilitate the routine use of our products for high definition news, motion picture and television cameras.

Reverse merger negotiations are proceeding as expected by the company but it is not the company's policy to comment on them until they are solidified. The initial timeline remains in place.

ULYSSES DIVERSIFIED HOLDINGS CORPORATION (OTC: UDHC)
"Up 30.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/UDHC.php

Ulysses Diversified Holdings Corporation operates in the retail optical industry in the United States. It owns, operates, and franchises optical stores that offer eyewear, including contact lenses and non designer eyeglasses and sunglasses. The company also offers designer eyewear. Ulysses Diversified Holdings Corporation was formerly known as Ulysses Holding Corp. and changed its name to Ulysses Diversified Holdings Corporation in May 2008. The company was incorporated in 1994 and is based in Jacksonville, New York.

UDHC News:

August 6 - Ulysses Diversified Holdings Corp. in Negotiations With a Major National Day Care Chain for Its SecureNetView Unit Products and Services

Ulysses Diversified Holdings Corporation (OTC: UDHC) announced it has entered into formal negotiations to supply a major national day care operator with one thousand (1,000) plus locations.

The contract will consist of providing each of all one thousand plus locations with SecureNetView's patented surveillance technology, this technology enables parents to monitor their children at the day care centers from any cell phone, computer or any other hand-held device.

The company estimates monthly revenue from this one client account will range between $680,000 and $750,000 per month for an annual revenue flow of $8,160,000 to $9,000,000.

"We are very pleased to have this opportunity and believe that we are in the final stretch of obtaining this very lucrative contract, I am confident that our team will complete this deal by week's end," said Clayton Young, President.

Mr. Young also added, "Due to the sensitivity of the finalization of the contract by both parties, the client will be announced upon the completion of all executed contracts."